Soligenix
SNGX
#10223
Rank
HK$0.12 B
Marketcap
HK$12.53
Share price
-1.23%
Change (1 day)
-49.67%
Change (1 year)

P/S ratio for Soligenix (SNGX)

P/S ratio as of December 2025 (TTM): N/A

According to Soligenix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.18. At the end of 2025 the company had a P/S ratio of N/A.

P/S ratio history for Soligenix from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
2025N/A-100%
202462.0102.81%
202330.6-60.9%
202278.2-90.79%
20218494189.27%
202019.8101.75%
20199.81155.78%
20183.83-14.46%
20174.48282.97%
20161.17-70.95%
20154.0321.05%
20143.33-69.62%
201311.0414.17%
20122.13166.77%
20110.7988-96.21%
201021.127.96%
200916.5523.38%
20082.64-79.35%
200712.879.41%
20067.1455.4%
20054.59-82.98%
200427.0
2001> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.8457N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.54N/A๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
2.36N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.29N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
10.4N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
92.5N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1.94N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel